Profitability Ratios
| Ratio |
Value |
| GP Margin |
70.0% |
| EBIT Margin |
11.6% |
| EBITDA Margin |
26.5% |
| Operating Margin |
16.2% |
| Pretax Margin |
6.6% |
| Cont. Ops Margin |
7.6% |
| Net Margin |
7.6% |
| Bottom Line Margin |
7.5% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
0.66 |
| Quick Ratio |
0.55 |
| Solvency Ratio |
0.096 |
| Cash Ratio |
0.14 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
73.48 |
| PEG Ratio |
-6.08 |
| Forward PEG |
-6.08 |
| Price/Book |
94.54 |
| Price/Sales |
5.58 |
| Price/FCF |
17.63 |
| Price/Op Cash Flow |
16.72 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.5019 |
| Debt/Equity |
20.4033 |
| Debt/Capital |
0.9533 |
| Long-Term Debt/Capital |
0.9478 |
| Financial Leverage |
40.65 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
-6.26 |
| Operating Cash Flow Ratio |
0.485 |
| Operating Cash Flow/Sales |
33.4% |
| Free Cash Flow/Operating Cash Flow |
94.8% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
1.61 |
| Interest Coverage |
3.2539 |
| Short-Term Operating Cash Flow Coverage |
2.76 |
| Operating Cash Flow Coverage |
0.28 |
| Capital Expenditure Coverage |
19.31 |
| Dividend + Capital Expenditure Coverage |
1.57 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
257.7139% |
| Dividend Yield |
3.5072% |
| Dividend Yield % |
3.5072% |
| Dividend Per Share |
6.2323 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
31.85 |
| EPS |
2.418 |
| Debt/Share |
39.9373 |
| Cash/Share |
3.14 |
| Book Value/Share |
1.90 |
| Tangible BV/Share |
-51.81 |
| Equity/Share |
1.88 |
| Operating Cash Flow/Share |
10.631 |
| Capital Expenditure/Share |
0.551 |
| FCF/Share |
10.080 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.151 |
| Earnings Before Tax/EBIT |
0.407 |
| Price/Fair Value |
94.54 |
| Debt/Market Cap |
0.2136 |
| Effective Tax Rate |
-15.3% |
| Enterprise Value Multiple |
25.26 |
ABBV - AbbVie Inc.